Krieg Arthur M Insider Trades

Insider Trading History

Track insider trading activity for Krieg Arthur M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $8.57M 815,734 shares
Last Trade
Jun 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$43.6k 7,224 shares
$6.04
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $8.49M 808,510 shares
Last Trade
Jun 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.1k 3,578 shares
$6.18
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
May 28, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$463k 68,457 shares
$6.76
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $8.45M 804,932 shares
Last Trade
May 18, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$174k 25,001 shares
$6.97
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $8.02M 764,179 shares
Last Trade
Mar 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$371k 33,220 shares
$11.16
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.84M 746,711 shares
Last Trade
Mar 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42.3k 3,484 shares
$12.15
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.8M 743,227 shares
Last Trade
Mar 25, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$124k 10,036 shares
$12.35
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.7M 733,191 shares
Last Trade
Jan 27, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.2k 1,701 shares
$13.05
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.68M 731,490 shares
Last Trade
Jan 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.55k 500 shares
$13.09
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.68M 730,990 shares
Last Trade
Dec 29, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.27k 443 shares
$14.16
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.67M 730,547 shares
Last Trade
Dec 22, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$74.7k 5,103 shares
$14.64
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.62M 725,444 shares
Last Trade
Dec 16, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$70.2k 4,805 shares
$14.62
$10.50
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals CMPI
Chief Scientific Officer
Holding Value $7.57M 720,639 shares
Last Trade
Dec 15, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$609 42 shares
$14.49
$10.50
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp, Chief Scientific Officer
Holding Value $4.47M 275,000 shares
Last Trade
Jan 13, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.52M 275,000 shares
$20.08
$16.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up